FDA approves Ionis-AstraZeneca's nerve disease drug

The U.S. Food and Drug Administration (FDA) on Thursday approved Ionis Pharmaceuticals (IONS.O) and partner AstraZeneca's (AZN.L) drug to treat nerve damage caused by a life-shortening rare disease.